| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 09/08/2004 | CN1165532C Substituted 3-cyanoquinolines as protein tyrosine kinase inhibitors |
| 09/08/2004 | CN1165526C Substituted phenyl cyclohexane carboxylic acid amides and their use as adenosine uptake inhibitors |
| 09/08/2004 | CN1165522C Bradykinin receptor antagonists |
| 09/07/2004 | US6787652 Lowering lipids and serum cholesterol without generating adverse cardiac effects; 4,5-dihydro-3,5-dioxo-1,2,4-triazine derivatives |
| 09/07/2004 | US6787651 Substituted indoles, pharmaceutical compounds containing such indoles and their use as PPAR-γ binding agents |
| 09/07/2004 | US6787561 Benzimidazole compounds |
| 09/07/2004 | US6787560 Serotonin reuptake inhibitor |
| 09/07/2004 | US6787558 Neuropeptide y receptor antagonists, for treating arthritis, cardiovascular diseases, diabetes, renal failure, eating disorders and obesity |
| 09/07/2004 | US6787556 Benzoic acid derivatives for the treatment of diabetes mellitus |
| 09/07/2004 | US6787555 Such as 4-(4-fluorophenyl)-5-(2-phenylmethylamino)pyrimidin-4-yl)-1-ethoxymethyl -(1,2,3)triazole for inhibition of release of inflammatory interleukins; for treatment of osteoarthritis, rheumatoid arthritis, and congestive heart failure |
| 09/07/2004 | US6787550 Indole derivatives and their use for the treatment of osteoporosis amongst other applications |
| 09/07/2004 | US6787546 Heterocycle derivatives and drugs |
| 09/07/2004 | US6787543 Preparation of tachykinin antagonists; substituted nitrogen-containing heterocycles |
| 09/07/2004 | US6787542 Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents |
| 09/07/2004 | US6787540 Compounds useful as reversible inhibitors of cysteine proteases |
| 09/07/2004 | US6787539 2,4,5,-trisubstituted pyrimidine derivatives |
| 09/07/2004 | US6787536 Hydroxamic acid derivatives |
| 09/07/2004 | US6787535 Indole derivatives with 5HT6 receptor affinity |
| 09/07/2004 | US6787534 Sulfonamide-containing heterocyclic compounds |
| 09/07/2004 | CA2140146C Process for preparing indole derivatives containing a 1,2,4-triazol-1-yl substituent |
| 09/02/2004 | WO2004074812A2 Library of biphenyl derivatives useful for identifying compounds having both beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity |
| 09/02/2004 | WO2004074502A2 A process of preparing imatinib |
| 09/02/2004 | WO2004074291A1 Triazole compounds useful in therapy |
| 09/02/2004 | WO2004074287A1 Novel compounds |
| 09/02/2004 | WO2004074280A1 Pyridine derivatives as fungicidal compounds |
| 09/02/2004 | WO2004074278A1 Novel compounds |
| 09/02/2004 | WO2004074277A1 N-aryl- or n-heteroarylpiperazine derivative and medicine containing the same |
| 09/02/2004 | WO2004074276A1 BIPHENYL DERIVATIVES HAVING β2 ADRENERGIC RECEPTOR AGONIST AND MUSCARINIC RECEPTOR ANTAGONIST ACTIVITY |
| 09/02/2004 | WO2004074275A1 Indazolamides with analgesic activity |
| 09/02/2004 | WO2004074274A1 Substituted n-aryl nitrogen heterocycles |
| 09/02/2004 | WO2004074273A1 Novel compounds |
| 09/02/2004 | WO2004074272A1 Anthelmintic agents and insecticidal compositions |
| 09/02/2004 | WO2004074260A1 Pyrimidine derivatives |
| 09/02/2004 | WO2004074259A1 Aryl acid pyrimidinyl methyl amides, pyridazinyl methyl amides and related compounds |
| 09/02/2004 | WO2004074258A1 Novel sulphated imidazole derivatives, method for production thereof, novel intermediates obtained, application thereof as medicaments and pharmaceutical compositions comprising the above |
| 09/02/2004 | WO2004074257A1 Non-nucleoside reverse transcriptase inhibitors |
| 09/02/2004 | WO2004074251A1 Derivatives of azasugars as anticancer agents |
| 09/02/2004 | WO2004074246A2 Biphenyl derivatives having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity |
| 09/02/2004 | WO2004074218A2 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 09/02/2004 | WO2004073634A2 Phenylenediamine urotensin-ii receptor antagonists and ccr-9 antagonists |
| 09/02/2004 | WO2004073619A2 Ccr8 antagonists |
| 09/02/2004 | WO2004058730A3 Triazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1 |
| 09/02/2004 | WO2004056319A3 Substituted n-phenyl sulfonamide bradykinin antagonists |
| 09/02/2004 | WO2004050637A3 2-(2-hydroxybiphenyl-3-yl)-1h-benzoimidazole-5-carboxamidine derivatives as factor viia inhibitors |
| 09/02/2004 | WO2004049797A3 Pesticidal sulphonylaminopyrazoles |
| 09/02/2004 | WO2004035569A3 Novel compounds with antibacterial activity |
| 09/02/2004 | WO2004014851A3 Tyrosine kinase inhibitors |
| 09/02/2004 | WO2003101954A3 Nf-kb inhibitors and uses thereof |
| 09/02/2004 | WO2003099786A3 Aromatic sulfones and their medical use |
| 09/02/2004 | WO2003084539A3 New pharmaceutical compositions based on anticholinergics and p38 kinase inhibitors |
| 09/02/2004 | US20040171881 N,N'-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 09/02/2004 | US20040171848 Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
| 09/02/2004 | US20040171844 Dihydro-2H-naphthalene-1-one inhibitors of ras farnesyl transferase |
| 09/02/2004 | US20040171833 Ligands for metals and improved metal-catalyzed processes based thereon |
| 09/02/2004 | US20040171818 relates to increasing product yield and decreasing process steps for intermediate and large scale production of bridged macrolides |
| 09/02/2004 | US20040171798 treatment of diseases regulated by the activation and degranulation of eosinophils, especially asthma, chronic bronchitis, and chronic obstructuive pulmonary disease |
| 09/02/2004 | US20040171665 Novel polymorphic form IV and solvate; precipitation from ethyl acetate |
| 09/02/2004 | US20040171655 Active against cancer proliferation, growth, and metastasis; such as 3,4,5-trimethoxy-n-(2-methyl-3-phenyl-allyl)-n-[2-(1-methyl-pyrrolidin-2-yl)-thyl]-benzamide; side effect reduction |
| 09/02/2004 | US20040171650 Fighting parasitic infections in human and animals; 1,2,4-triazol-3-thioyl derivatives |
| 09/02/2004 | US20040171649 Intermediates for anthranilic amide insecticides and blood coagulation factor Xa inhibitors |
| 09/02/2004 | US20040171641 Arylpiperazines and their use as metalloproteinase inhibiting agents (MMP) |
| 09/02/2004 | US20040171638 Chemokine receptor binding heterocyclic compounds |
| 09/02/2004 | US20040171634 Anticancer, antitumor agents, antiarthritic agents |
| 09/02/2004 | US20040171628 Benzo [g] quinoline derivatives for treating glaucoma and myopia |
| 09/02/2004 | US20040171627 quinazolinone derivatives, especially halofuginone, can also inhibit the pathophysiological processes of renal fibrosis in vivo, including the effect on both the glomeruli and the tubuli interstitial compartments |
| 09/02/2004 | US20040171626 having good to very good inhibitory activity against HCV polymerase; hepatitis C virus |
| 09/02/2004 | US20040171620 Nitrogen-containing bicyclic heterocycles for use as antibacterials |
| 09/02/2004 | US20040171618 Compounds as PDE IV and TNF-inhibitors |
| 09/02/2004 | US20040171617 treatment for disorders and diseases, such as chronic inflammation, tissue breakdown and cancer |
| 09/02/2004 | US20040171614 Novel gamma secretase inhibitors |
| 09/02/2004 | US20040171612 Novel compounds with analgesic effect |
| 09/02/2004 | US20040171606 antagonism/inhibition, of the D3 receptor; substance abuse. |
| 09/02/2004 | US20040171604 strong antithrombotic effect and are suitable, for example, for the therapy and prophylaxis of cardiovascular disorders like thromboembolic diseases or restenoses |
| 09/02/2004 | US20040171520 Melanocortin receptor-specific peptidomimetics |
| 09/02/2004 | US20040171490 Preventing infestation of plants by phytopathogenic microorganisms; horticulture, agriculture |
| 09/02/2004 | US20040171075 Modulation of protein functionalities |
| 09/02/2004 | US20040170634 Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors |
| 09/02/2004 | DE10307845A1 Heterocyclische Amide, Verfahren zu ihrer Herstellung, sie enthaltende Mittel und ihre Verwendung als Schädlingsbekämpfungsmittel Heterocyclic amides, processes for their preparation, compositions containing them and their use as pesticides |
| 09/02/2004 | DE10307142A1 Substituierte N-Aryl-Stickstoffheterocyclen Substituted N-aryl nitrogen heterocycles |
| 09/02/2004 | CA2767153A1 Phenylenediamine urotensin-ii receptor antagonists and ccr-9 antagonists |
| 09/02/2004 | CA2516748A1 Anthelmintic agents and insecticidal compositions |
| 09/02/2004 | CA2516590A1 Substituted n-aryl nitrogen heterocycles |
| 09/02/2004 | CA2515777A1 Biphenyl derivatives |
| 09/02/2004 | CA2514862A1 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 09/02/2004 | CA2508731A1 Aryl acid pyrimidinyl methyl amides, pyridazinyl methyl amides and related compounds |
| 09/01/2004 | EP1453087A1 Microelectronic assembly |
| 09/01/2004 | EP1452533A1 Crystalline form Z of rabeprazole sodium and process for preparation thereof |
| 09/01/2004 | EP1452528A1 Xanthine oxidase inhibitors |
| 09/01/2004 | EP1452527A1 Azabicyclo compound, matrix metalloprotease inhibitor, and skin preparation |
| 09/01/2004 | EP1452526A1 Indole compound and medicinal use thereof |
| 09/01/2004 | EP1452525A1 Amide derivatives and drugs |
| 09/01/2004 | EP1452524A1 "2-oxo-1-pyrrolidine derivative and its pharmaceutical uses" |
| 09/01/2004 | EP1451185A1 Indole-2-carboxamides as factor xa inhibitors |
| 09/01/2004 | EP1451177A1 Substituted 2-pyrrolidine-2-yl-1h-indole derivatives for the treatment of migraine |
| 09/01/2004 | EP1451176A2 Benzazepine derivatives and their use as 5-ht ligands |
| 09/01/2004 | EP1451175A1 Thrombin inhibitors |
| 09/01/2004 | EP1451174A2 Process for the preparation of compositions having an increased amount of pharmaceutically active salts of rotamers |
| 09/01/2004 | EP1451173A2 Piperidines |
| 09/01/2004 | EP1451172A1 Therapeutic isoquinoline compounds |
| 09/01/2004 | EP1451167A1 Phenylalkynes |